Edap Tms (EDAP) Interest & Investment Income (2009 - 2026)
Edap Tms (EDAP) reported Interest & Investment Income of -$1.7 million for Q1 2026, down 11526.67% on a YoY basis from N/an in Q1 2025, and down 11526.67% quarter-over-quarter from $15000.0 in Q1 2025.
Edap Tms (EDAP) Interest & Investment Income (2009 - 2026) Analysis & Trends
Edap Tms has reported Interest & Investment Income for 3 years, with the latest figure at -$1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 11526.67% year-over-year to -$1.7 million; the trailing twelve-month figure through Jun 2009 stood at -$2.0 million (changed N/A YoY), and the FY2025 full-year result was -$3.1 million, down 613.2% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$1.7 million, down from $15000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $15000.0 in Q1 2025, with the low at -$1.7 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | - |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -140.46 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 7.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.71 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 46,673.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.71 Mn |
| Mar 31, 2025 | 15,000.00 |
| Jun 30, 2009 | -1.99 Mn |